Form 8-K/A BIOMARIN PHARMACEUTICAL For: Apr 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
BioMarin completes acquisition of Amicus Therapeutics
July 13, 2026 4:15 PM EDTBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has completed its acquisition of Amicus Therapeutics, Inc., according to a filing with the U.S. Securities and Exchange Commission.
BioMarin filed a Current Report on Form 8-K on April 27, 2026, disclosing the consummation of the deal. Under the terms... More
